Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174053 | SCV000225287 | uncertain significance | not provided | 2015-01-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081245 | SCV000650917 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000174053 | SCV001941292 | benign | not provided | 2018-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399620 | SCV002712432 | benign | Cardiovascular phenotype | 2019-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000174053 | SCV003833604 | benign | not provided | 2023-08-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150045 | SCV003838354 | benign | Cardiomyopathy | 2021-09-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004700532 | SCV005202368 | benign | not specified | 2024-07-28 | criteria provided, single submitter | clinical testing |